RCAN1 is an Important Mediator of Glucocorticoid-induced Apoptosis in Human Leukemic Cells

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2012 Nov 28

PMID 23185487

Citations 10

Authors

Kazuaki Nagao

Yujiro Iwai

Toshiyuki Miyashita

Affiliations

Soon will be listed here.

Abstract

Glucocorticoid (GC) is a major therapeutic agent for the treatment of leukemia because of its ability to induce apoptosis in lymphoid cells. The mechanism causing apoptosis, however, is still controversial. Since the glucocorticoid receptor is a transcription factor, some of its target genes are expected to be implicated in apoptosis. In this study, using a GC-sensitive human pre-B leukemia cell line, Nalm-6, the FK506 binding protein 51 (FKBP5) and regulator of calcineurin 1 (RCAN1) genes were disrupted by homologous recombination, since the expression of both is up-regulated by GC in GC-sensitive but not in GC-resistant leukemic cell lines. While the disruption of FKBP5 had a marginal effect on GC-induced apoptosis, that of RCAN1 resulted in marked resistance to GC. In addition, overexpression of RCAN1 rendered cells more sensitive to DEX. In RCAN1-disrupted cells, levels of some pro-apoptotic and anti-apoptotic Bcl-2 family proteins were decreased and increased, respectively. Finally, phosphorylation of cAMP-response element binding protein (CREB) and up-regulation of CREB target genes by GC were inhibited by RCAN1 disruption, and treatment with a cAMP-inducing agent, forskolin, restored the sensitivity to GC in RCAN1-disrupted Nalm-6 cells. These findings suggest that up-regulation of RCAN1 expression followed by activation of the CREB pathway is required in GC-induced apoptosis.

Citing Articles

PU.1 eviction at lymphocyte-specific chromatin domains mediates glucocorticoid response in acute lymphoblastic leukemia.

Beck D, Cao H, Tian F, Huang Y, Jiang M, Zhao H Nat Commun. 2024; 15(1):9697.

PMID: 39516193 PMC: 11549222. DOI: 10.1038/s41467-024-54096-2.

RCAN1-mediated calcineurin inhibition as a target for cancer therapy.

Lao M, Zhang X, Yang H, Bai X, Liang T Mol Med. 2022; 28(1):69.

PMID: 35717152 PMC: 9206313. DOI: 10.1186/s10020-022-00492-7.

PTCH1-null induced pluripotent stem cells exclusively differentiate into immature ectodermal cells with large areas of medulloblastoma-like tissue.

Nagao K, Kato C, Ikemoto Y, Motojima T, Fujii K, Umezawa A Discov Oncol. 2022; 13(1):36.

PMID: 35618979 PMC: 9135936. DOI: 10.1007/s12672-022-00498-x.

The long noncoding RNA HOTAIRM1 controlled by AML1 enhances glucocorticoid resistance by activating RHOA/ROCK1 pathway through suppressing ARHGAP18.

Liang L, Gu W, Li M, Gao R, Zhang X, Guo C Cell Death Dis. 2021; 12(7):702.

PMID: 34262023 PMC: 8280127. DOI: 10.1038/s41419-021-03982-4.

Prostaglandin E2 stimulates cAMP signaling and resensitizes human leukemia cells to glucocorticoid-induced cell death.

Roderick J, Gallagher K, Murphy L, OConnor K, Tang K, Zhang B Blood. 2021; 137(4):500-512.

PMID: 33507291 PMC: 7845005. DOI: 10.1182/blood.2020005712.

References

Nagao K, Toyoda M, Takeuchi-Inoue K, Fujii K, Yamada M, Miyashita T . Identification and characterization of multiple isoforms of a murine and human tumor suppressor, patched, having distinct first exons. Genomics. 2005; 85(4):462-71. DOI: 10.1016/j.ygeno.2004.11.014. View

Khoshnan A, Tindell C, Laux I, Bae D, Bennett B, Nel A . The NF-kappa B cascade is important in Bcl-xL expression and for the anti-apoptotic effects of the CD28 receptor in primary human CD4+ lymphocytes. J Immunol. 2000; 165(4):1743-54. DOI: 10.4049/jimmunol.165.4.1743. View

Kim S, Seo S . The regulator of calcineurin 1 (RCAN1/DSCR1) activates the cAMP response element-binding protein (CREB) pathway. J Biol Chem. 2011; 286(43):37841-8. PMC: 3199525. DOI: 10.1074/jbc.M111.232165. View

Myklebust J, Josefsen D, Blomhoff H, Levy F, Naderi S, Reed J . Activation of the cAMP signaling pathway increases apoptosis in human B-precursor cells and is associated with downregulation of Mcl-1 expression. J Cell Physiol. 1999; 180(1):71-80. DOI: 10.1002/(SICI)1097-4652(199907)180:1<71::AID-JCP8>3.0.CO;2-N. View

Zhao Y, Guo X, Ma Z, Gu L, Ge J, Li Q . Pro-apoptotic protein BIM in apoptosis of glucocorticoid-sensitive and -resistant acute lymphoblastic leukemia CEM cells. Med Oncol. 2010; 28(4):1609-17. DOI: 10.1007/s12032-010-9641-x. View

Hirakawa Y, Nary L, Medh R . Glucocorticoid evoked upregulation of RCAN1-1 in human leukemic CEM cells susceptible to apoptosis. J Mol Signal. 2009; 4:6. PMC: 2745384. DOI: 10.1186/1750-2187-4-6. View

Yang J, Rothermel B, Vega R, Frey N, McKinsey T, Olson E . Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles. Circ Res. 2000; 87(12):E61-8. DOI: 10.1161/01.res.87.12.e61. View

Srivastava R, Srivastava A, Korsmeyer S, Nesterova M, Cho-Chung Y, Longo D . Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase. Mol Cell Biol. 1998; 18(6):3509-17. PMC: 108932. DOI: 10.1128/MCB.18.6.3509. View

Sun X, Wu Y, Chen B, Zhang Z, Zhou W, Tong Y . Regulator of calcineurin 1 (RCAN1) facilitates neuronal apoptosis through caspase-3 activation. J Biol Chem. 2011; 286(11):9049-62. PMC: 3059004. DOI: 10.1074/jbc.M110.177519. View

10.

Lu Yoshida N, Miyashita T, U M, Yamada M, Reed J, Sugita Y . Analysis of gene expression patterns during glucocorticoid-induced apoptosis using oligonucleotide arrays. Biochem Biophys Res Commun. 2002; 293(4):1254-61. DOI: 10.1016/S0006-291X(02)00361-3. View

11.

Xu W, Kasper L, Lerach S, Jeevan T, Brindle P . Individual CREB-target genes dictate usage of distinct cAMP-responsive coactivation mechanisms. EMBO J. 2007; 26(12):2890-903. PMC: 1894772. DOI: 10.1038/sj.emboj.7601734. View

12.

Rogatsky I, Ivashkiv L . Glucocorticoid modulation of cytokine signaling. Tissue Antigens. 2006; 68(1):1-12. DOI: 10.1111/j.1399-0039.2006.00599.x. View

13.

Lawen A . Apoptosis-an introduction. Bioessays. 2003; 25(9):888-96. DOI: 10.1002/bies.10329. View

14.

Simons Jr S, Sistare F, Chakraborti P . Steroid binding activity is retained in a 16-kDa fragment of the steroid binding domain of rat glucocorticoid receptors. J Biol Chem. 1989; 264(24):14493-7. View

15.

Davies T, Ning Y, Sanchez E . A new first step in activation of steroid receptors: hormone-induced switching of FKBP51 and FKBP52 immunophilins. J Biol Chem. 2001; 277(7):4597-600. DOI: 10.1074/jbc.C100531200. View

16.

Tissing W, Meijerink J, den Boer M, Pieters R . Molecular determinants of glucocorticoid sensitivity and resistance in acute lymphoblastic leukemia. Leukemia. 2003; 17(1):17-25. DOI: 10.1038/sj.leu.2402733. View

17.

Martinez-Martinez S, Genesca L, Rodriguez A, Raya A, Salichs E, Were F . The RCAN carboxyl end mediates calcineurin docking-dependent inhibition via a site that dictates binding to substrates and regulators. Proc Natl Acad Sci U S A. 2009; 106(15):6117-22. PMC: 2669349. DOI: 10.1073/pnas.0812544106. View

18.

Schlossmacher G, Stevens A, White A . Glucocorticoid receptor-mediated apoptosis: mechanisms of resistance in cancer cells. J Endocrinol. 2011; 211(1):17-25. DOI: 10.1530/JOE-11-0135. View

19.

Poppek D, Keck S, Ermak G, Jung T, Stolzing A, Ullrich O . Phosphorylation inhibits turnover of the tau protein by the proteasome: influence of RCAN1 and oxidative stress. Biochem J. 2006; 400(3):511-20. PMC: 1698600. DOI: 10.1042/BJ20060463. View

20.

Jackson A, Bartz S, Schelter J, Kobayashi S, Burchard J, Mao M . Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol. 2003; 21(6):635-7. DOI: 10.1038/nbt831. View